TY  - JOUR
TI  - Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis
AB  - The use of anti-tumor necrosis factor alpha (anti-TNF-α) agents has increased during the past decadein rheumatology practice. Opportunistic infections have been reported with anti-TNF-α agents inclinical trials and post-marketing usage. Aspergillus infection is a rare opportunistic infection that isassociated with immunosuppression, and there are reported cases of pulmonary aspergillosis in var-ious rheumatic diseases treated with anti-TNF-α agents. Here, we present the first case of pulmonaryaspergillosis associated with infliximab treatment in a patient with Still’s disease.
AU  - Kılıç, Levent
AU  - Arikan-Akdagli, Sevtap
AU  - AKDOĞAN, Ali
AU  - ERDEN, Abdülsamet
AU  - ŞEYHOĞLU, Emrah
AU  - KALYONCU, Umut
AU  - KARADAĞ, ÖMER
DO  - 10.5152/eurjrheum.2016.15081
PY  - 2018
JO  - European Journal of Rheumatology
VL  - 5
IS  - 1
SN  - 2147-9720
SP  - 75
EP  - 78
DB  - TRDizin
UR  - http://search/yayin/detay/309469
ER  -